T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBAI
2326
DELISTED
Lakeland Bancorp Inc
LBAI
| $323K | ﹤0.01% |
17,869
-430
| -2% | -$8.35K |
|
|
SRNE
2327
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $322K | ﹤0.01% |
73,226
+24,653
| +51% | +$137K |
|
|
DS
2328
DELISTED
Drive Shack Inc.
DS
| $321K | ﹤0.01% |
53,870
-1,643
| -3% | -$10.4K |
|
2329
Gates Industrial Corporation Ltd.
GTES
$7.05B
| $320K | ﹤0.01% |
16,386
+1,882
| +13% | +$32.9K |
|
|
CRR
2330
DELISTED
Carbo Ceramics Inc.
CRR
| $319K | ﹤0.01% |
43,945
-1,586
| -3% | -$13.9K |
|
2331
Universal Electronics
UEIC
$75.8M
| $318K | ﹤0.01% |
8,083
| – | – |
|
2332
Chefs' Warehouse
CHEF
$4.53B
| $315K | ﹤0.01% |
8,656
+132
| +2% | +$4.08K |
|
2333
Central Pacific Financial
CPF
$997M
| $315K | ﹤0.01% |
11,935
+170
| +1% | +$4.82K |
|
|
COWN
2334
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $314K | ﹤0.01% |
19,251
+174
| +0.9% | +$2.6K |
|
|
TMHC
2335
DELISTED
Taylor Morrison
TMHC
| $313K | ﹤0.01% |
17,325
+385
| +2% | +$7.65K |
|
2336
Asure Software
ASUR
$241M
| $312K | ﹤0.01% |
+25,146
| New | +$366K |
|
2337
Genesco
GCO
$391M
| $312K | ﹤0.01% |
6,627
+116
| +2% | +$5.06K |
|
|
PGNX
2338
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $312K | ﹤0.01% |
49,709
-546
| -1% | -$4.19K |
|
2339
ATN International
ATNI
$478M
| $311K | ﹤0.01% |
4,203
+34
| +0.8% | +$2.28K |
|
2340
iShares MSCI Australia ETF
EWA
$1.46B
| $307K | ﹤0.01% |
13,900
+1,100
| +9% | +$24.8K |
|
2341
Federated Hermes
FHI
$4.7B
| $307K | ﹤0.01% |
12,734
+359
| +3% | +$8.44K |
|
2342
Stoneridge
SRI
$197M
| $307K | ﹤0.01% |
10,322
+156
| +2% | +$4.95K |
|
2343
iShares MSCI Switzerland ETF
EWL
$2.22B
| $305K | ﹤0.01% |
8,800
-600
| -6% | -$20.6K |
|
|
GG
2344
DELISTED
Goldcorp Inc
GG
| $305K | ﹤0.01% |
30,000
+5,600
| +23% | +$65.6K |
|
2345
Griffon
GFF
$4.75B
| $304K | ﹤0.01% |
18,809
+327
| +2% | +$5.84K |
|
2346
Ennis
EBF
$556M
| $303K | ﹤0.01% |
14,799
+100
| +0.7% | +$2.11K |
|
|
RVI
2347
DELISTED
Retail Value Inc. Common Shares
RVI
| $303K | ﹤0.01% |
+101,024
| New | +$314K |
|
2348
Abercrombie & Fitch
ANF
$4.99B
| $302K | ﹤0.01% |
14,294
+206
| +1% | +$5K |
|
2349
Citizens
CIA
$199M
| $302K | ﹤0.01% |
36,008
-495
| -1% | -$3.97K |
|
2350
Immersion
IMMR
$247M
| $302K | ﹤0.01% |
28,555
-414
| -1% | -$5.17K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.